Scarica l'app Stockscreener
73.69
0.50%
0.37
Dopo l'orario di chiusura:
73.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$73.32
Aprire:
$73.42
Volume 24 ore:
4.99M
Relative Volume:
0.68
Capitalizzazione di mercato:
$93.46B
Reddito:
$386.46B
Utile/perdita netta:
$4.49B
Rapporto P/E:
20.58
EPS:
3.58
Flusso di cassa netto:
$4.78B
1 W Prestazione:
+2.15%
1M Prestazione:
+19.92%
6M Prestazione:
+14.76%
1 anno Prestazione:
+24.27%
Intervallo 1D:
$72.91
$73.91
Intervallo di 1 settimana:
$72.16
$74.53
Portata 52W:
$43.56
$74.53
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
73.69 | 93.97B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
310.38 | 279.67B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
304.03 | 80.27B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
308.05 | 72.58B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
312.00 | 37.29B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Canada Pension Plan Investment Board Buys 123,037 Shares of CVS Health Corporation $CVS - MarketBeat
Caisse DE Depot ET Placement DU Quebec Reduces Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
OMERS ADMINISTRATION Corp Sells 7,705 Shares of CVS Health Corporation $CVS - MarketBeat
Key metrics from CVS Health Corporation’s quarterly dataEarnings Risk Report & High Yield Stock Recommendations - Newser
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
63% of Americans Plan Flu Shots: CVS Health Expands with 3-in-1 Testing in 38 States for 2025-2026 - Stock Titan
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Volatility clustering patterns for CVS Health Corporation2025 Risk Factors & Weekly Setup with ROI Potential - Newser
CVS Health Corporation $CVS Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Is CVS Health Corporation forming a double bottomJuly 2025 Breakouts & Growth Focused Stock Reports - khodrobank.com
How high can CVS Health Corporation stock goWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
CVS Health Corporation $CVS Shares Sold by Rafferty Asset Management LLC - MarketBeat
Ieq Capital LLC Purchases 180,495 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health stock hits 52-week high at 73.26 USD - Investing.com
Former CVS CFO Guertin joins board of Aledade, largest US primary care networkProvidence Business First - The Business Journals
Price momentum metrics for CVS Health Corporation explained2025 Dividend Review & Growth-Oriented Investment Plans - Newser
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift - The Herald Palladium
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure - sharewise.com
CVS Health Sees Momentum In HCB Segment Amid Utilization Pressure - Barchart.com
Cvs Health stock hits 52-week high at 73.26 USD By Investing.com - Investing.com Australia
Connecticut Wealth Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS agrees to pay Massachusetts $12M to settle Medicaid overbilling claims - Yahoo Finance
Guggenheim Capital LLC Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
Landscape Capital Management L.L.C. Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
290,000 Shares in CVS Health Corporation $CVS Purchased by Callodine Capital Management LP - MarketBeat
Gamco Investors INC. ET AL Sells 8,857 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Evergreen Capital Management LLC - MarketBeat
Is CVS Health Corporation’s ROIC above industry averageJuly 2025 Rallies & Verified Entry Point Signals - khodrobank.com
Trexquant Investment LP Acquires 97,097 Shares of CVS Health Corporation $CVS - MarketBeat
Understanding CVS Health Corporation’s price movementWeekly Trade Analysis & Accurate Buy Signal Alerts - Newser
Gabelli Funds LLC Sells 28,500 Shares of CVS Health Corporation $CVS - MarketBeat
Advanced analytics toolkit walkthrough for CVS Health CorporationTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Custom watchlist performance reports with CVS Health CorporationWeekly Trend Recap & High Accuracy Swing Trade Signals - Newser
Using R and stats models for CVS Health Corporation forecastingMarket Growth Summary & Daily Risk Controlled Trade Plans - Newser
CVS Pharmacy Alters COVID-19 Vaccine Access Amid New FDA Guidelines - AInvest
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Can CVS Health's Recent Earnings Weakness Be a Buying Opportunity Amid Stronger Fundamentals? - AInvest
Can CVS Health Corporation's (NYSE:CVS) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? - Yahoo Finance
480,677 Shares in CVS Health Corporation $CVS Bought by Junto Capital Management LP - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
4.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):